Partner With Us. Together We’ll Build Better Antibodies.

Today’s industry-standard discovery process consists of a series of discrete steps using disparate technologies and methods that only support end-point decision-making. Our process, driven by a single platform—the RubrYc Discovery Engine—enables real-time decision-making, saving time and money.

Functional epitope maps enable improved discrimination in hit selection very early in our discovery campaigns. We observe and maintain specificity and selectivity throughout discovery and developability. You can count on a shorter timeframe for development, improved efficiency, and fewer risks and setback due to unforeseen off-target binding events. 

Current Industry-Standard Discovery

Involves discrete steps using disparate technologies and methods

RubrYc Pipeline Pre-Clinical Stages of Development

Involves integrated rational discovery & real-time decision making

We look forward to expanding our pipeline in partnerships with other companies initiating discovery programs